Download presentation
Presentation is loading. Please wait.
2
Nutrition in Chronic Pancreatitis
AGA Institute • Fellows’ Nutrition Course 2007 Rosemont/Chicago, Illinois • November 10, 2007 John A. Martin, M.D. Associate Professor of Medicine and Surgery Director of Endoscopy Northwestern University Feinberg School of Medicine • Chicago, Illinois
3
Chronic Pancreatitis Today’s focus on The disease The symptoms
Nutritional issues
4
Chronic Pancreatitis: The Disease
Chronic inflammation of pancreas Mononuclear cell infiltrate Fibrosis/calcification/irreversible anatomic changes Characteristic duct changes With or without calcification Affects exocrine and/or endocrine organ (including alpha cells)
5
Chronic Pancreatitis: The Disease
Multiple etiologies EtOH (80%) Hereditary CF Others Tropical Trauma/chronic duct obstruction Pancreas divisum Recurrent acute Idiopathic
6
Chronic Pancreatitis: The Disease
Malnutrition results from Pain Decreased nutrient digestion (esp. fat) → malabsorption >90% loss panc exocr fxn)
7
Chronic Pancreatitis: The Symptoms
Pain Constant or recurrent May be exacerbated by meals, alcohol May recur without recurrent acute inflammation Treatment Analgesia Hydration NPO EtOH abstinence
8
Chronic Pancreatitis: The Symptoms
Maldigestion with secondary malabsorption Steatorrhea Malnutrition Caloric Vitamin deficiencies Mineral deficiencies Weight loss
9
Chronic Pancreatitis: Nutritional Issues
Etiologies Maldigestion (a late symptom of CP) Pancreatic exocrine insufficiency (PEI): >90% function loss Malabsorption Maldigestion losses (with or without steatorrhea) Fat-soluble vitamins B12 due to R-factor dysfunction
10
Chronic Pancreatitis: Nutritional Issues
Etiologies Decreased oral intake Glucose intolerance / diabetes (50-90%) Poor glycemic control (can also be assoc with impaired glucagon release in up to 30%) Endorgan manifestations Gastroparesis Nausea Diarrhea/constipation Alcoholism Increased metabolic activity (30-50%) Hebuterne, et al., 1996
11
Chronic Pancreatitis: Diagnosis
Diagnosis: imaging AXR: parenchymal ± intraductal calcifications CT: calcifications (incl stones), inflammatory enlargement/mass, atrophy (relative), duct changes MR: similar to CT EUS: as above; also lobulation, hyperechoic foci/stranding, hyperechoic duct margin ERCP: calcifications/stones, characteristic duct changes
12
Chronic Pancreatitis: Diagnosis
Diagnosis: function testing Fecal elastase Fecal fat Quant: 72 hr stool fat: 100g fat diet, >7g fat excr/24 hrs Qualitative: spot oil-red O Secretin stim testing Indirect testing (e.g., Bentiromide test in past)
13
PEI: diagnosis Symptoms, clinical suspicion Steatorrhea Weight loss
Lipolytic function decreases more rapid than proteolytic Weight loss Hypovitaminosis (A, D, E, K, B12): uncommon Mineral deficiencies Ca Mg Zn Thiamine Folate
14
PEI: diagnosis Function testing Direct Indirect
Secretin, CCK stim testing Indirect Fecal fat Fecal elastase, chymotrypsin Pancreolauryl test Breath tests (13C)
15
Chronic pancreatitis: overall nutritional management strategy
Basic (majority of CP patients) EtOH abstinence Dietary modification Pancreatic enzyme supplementation Advanced (minority of CP patients) Oral supplementation (~10%) Enteral nutrition (~5%) Parenteral nutrition (<1%)
16
PEI: nutritional management
Dietary modification Increase caloric intake (↑ resting energy requirements) Decrease dietary fat (~30%) Increase dietary protein (1 gm/kg BW/d) Increase carbohydrate (except in DM); ± ↓ fiber Oral MCT supplementation Vitamin supplementation Mineral supplementation
17
PEI: nutritional management
Enteral nutrition: indications in CP Pain Anatomical etiologies of ↓ intake Due to CP Postoperative complications Recurrent/frequent pancreatitis exacerbations RAP Pain exacerbations of CP Complications of DM
18
PEI: nutritional management
Enteral nutrition: routes of delivery in CP NJ PEG PEG-J D-PEJ Enteral nutrition: formulas in CP Not well-studied: semi-elemental diet often recommended by experts
19
PEI: nutritional management
Parenteral nutrition (rarely needed/indicated) Anatomical reasons Fistula Short-term treatment of severe malnutrition Preop
20
PEI: pharmacological management
Enzyme supplementation No “set dose” Generally start with 2 caps AC + titrate Monitor sx’s (steatorrhea) or (re)check fecal fat Acid suppression to preserve activity Clinical value of coating/encapsulation not well-studied
21
PEI: pharmacological management
Antioxidants Analgesic therapy Opiates Tricyclics, etc. Non-steroidals Uncoated enzymes Treatment of diabetes Insulin, OHGs Gastroparesis management Anti-emetics Anti-diarrheals
22
Summary Major symptomatic manifestations of CP are all nutrition-related, and all multifactorial Pain Maldigestion/malabsorption/malnutrition DM Nutritional management of CP includes Dietary modification in almost all Enteral nutrition in few Parenteral nutrition in exceedingly few Pharmacological management of CP includes Analgesia Enzyme supplementation Treatment of DM and its endorgan manifestations Treatment of nausea and other symptoms Rigorous studies are lacking in nutritional aspects of CP management
23
INTESTINAL REHABILITATION CENTER NORTHWESTERN UNIVERSITY
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.